Drug Rhythm-Control Failure Widens Opening For Ablation, Say Cardiologists
Drug-based rhythm-control therapy does not help keep patients with atrial fibrillation and heart failure alive any better than conventional heart failure drugs, researchers report in the June 19 New England Journal of Medicine
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
